Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  260,386 results for ""Gemcitabine""

Your Filters

Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Nrf2-mediated adenylosuccinate lyase promotes resistance to gemcitabine in pancreatic ductal adenocarcinoma cells through ferroptosis escape.

  • Authors : Hsu TW; Graduate Institute of Medical Sciences, College of Medicine, Taipei Medical University, Taipei, Taiwan.; Department of Surgery, Division of General Surgery, Shuang Ho Hospital, Taipei Medical University, New Taipei City, Taiwan.

Subjects: Gemcitabine* ; Deoxycytidine*/Deoxycytidine*/Deoxycytidine*/analogs & derivatives ; Deoxycytidine*/Deoxycytidine*/Deoxycytidine*/pharmacology

  • Source: Journal of cellular physiology [J Cell Physiol] 2024 Dec; Vol. 239 (12), pp. e31416. Date of Electronic Publication: 2024 Aug 20.Publisher: Wiley-Liss Country of Publication: United States NLM ID: 0050222 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Interleukin-1 receptor 1 deficiency worsens hepatocellular carcinoma, while gemcitabine treatment alleviates the hepatocellular carcinoma-induced increase in intra-hepatic immune cells.

  • Authors : Chu CS; Ph.D. Program of Interdisciplinary Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan.; Ever Health Clinic, Taichung, Taiwan.

Subjects: Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/immunology ; Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/pathology ; Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/drug therapy

  • Source: Journal of gastroenterology and hepatology [J Gastroenterol Hepatol] 2024 Oct; Vol. 39 (10), pp. 2208-2218. Date of Electronic Publication: 2024 Jul 15.Publisher: Blackwell Scientific Publications Country of Publication: Australia NLM ID: 8607909 Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

YAP-LAMB3 axis dictates cellular resistance of pancreatic ductal adenocarcinoma cells to gemcitabine.

  • Authors : Li Y; Department of General Surgery, The Second Affiliated Hospital of Soochow University, Suzhou, China.; Wang X

Subjects: Gemcitabine* ; Deoxycytidine*/Deoxycytidine*/Deoxycytidine*/analogs & derivatives ; Deoxycytidine*/Deoxycytidine*/Deoxycytidine*/pharmacology

  • Source: Molecular carcinogenesis [Mol Carcinog] 2024 Oct; Vol. 63 (10), pp. 1953-1966. Date of Electronic Publication: 2024 Jul 17.Publisher: Wiley-Liss Country of Publication: United States NLM ID: 8811105 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Radiation recall reaction induced by gemcitabine/docetaxel in children: A retrospective study on risk factors and outcomes.

  • Authors : Larrosa C; Extracranial Solid Tumors Unit, Pediatric Cancer Center Barcelona, Barcelona, Spain.; Mico S

Subjects: Gemcitabine* ; Deoxycytidine*/Deoxycytidine*/Deoxycytidine*/analogs & derivatives ; Deoxycytidine*/Deoxycytidine*/Deoxycytidine*/adverse effects

  • Source: Pediatric blood & cancer [Pediatr Blood Cancer] 2024 Oct; Vol. 71 (10), pp. e31221. Date of Electronic Publication: 2024 Jul 31.Publisher: John Wiley Country of Publication: United States NLM ID: 101186624 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Design optimization of Fucoidan-coating Cationic Liposomes for enhance Gemcitabine delivery.

  • Authors : Silli EK; School of Life Sciences and Technology, China Pharmaceutical University, Nanjing, Jiangsu, 211198, China.; Zheng Z

Subjects: Gemcitabine* ; Deoxycytidine*/Deoxycytidine*/Deoxycytidine*/analogs & derivatives ; Deoxycytidine*/Deoxycytidine*/Deoxycytidine*/administration & dosage

  • Source: Investigational new drugs [Invest New Drugs] 2024 Oct; Vol. 42 (5), pp. 518-530. Date of Electronic Publication: 2024 Aug 18.Publisher: Springer Country of Publication: United States NLM ID: 8309330 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

SMYD2 Imparts Gemcitabine Resistance to Pancreatic Adenocarcinoma Cells by Upregulating EVI2A.

  • Authors : Jin L; Department of Gastroenterology, The Second Affiliated Hospital of Wannan Medical College, No. 10, Kangfu Road, Jinghu District, Wuhu, 241000, Anhui, People's Republic of China. .; Qian D

Subjects: Gemcitabine* ; Deoxycytidine*/Deoxycytidine*/Deoxycytidine*/analogs & derivatives ; Deoxycytidine*/Deoxycytidine*/Deoxycytidine*/pharmacology

  • Source: Molecular biotechnology [Mol Biotechnol] 2024 Oct; Vol. 66 (10), pp. 2920-2933. Date of Electronic Publication: 2023 Oct 09.Publisher: Springer Country of Publication: Switzerland NLM ID: 9423533 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Improved Antitumor Efficiency of N 4 -Tetradecyloxycarbonyl Gemcitabine-Loaded Liposomes for Pancreatic Cancer Chemotherapy.

  • Authors : Wang D; Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, 100050, People's Republic of China.; Wang X

Subjects: Deoxycytidine*/Deoxycytidine*/Deoxycytidine*/analogs & derivatives ; Deoxycytidine*/Deoxycytidine*/Deoxycytidine*/chemistry ; Deoxycytidine*/Deoxycytidine*/Deoxycytidine*/pharmacology

  • Source: International journal of nanomedicine [Int J Nanomedicine] 2024 Dec 11; Vol. 19, pp. 13391-13410. Date of Electronic Publication: 2024 Dec 11 (Print Publication: 2024).Publisher: DOVE Medical Press Country of Publication: New Zealand NLM ID: 101263847 Publication Model: eCollection Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Comparative Cost-Effectiveness of Gemcitabine and Cisplatin in Combination with S-1, Durvalumab, or Pembrolizumab as First-Line Triple Treatment for Advanced Biliary Tract Cancer.

  • Authors : Kashiwa M; Faculty of Pharmacy, Institute of Medical Pharmaceutical and Health Sciences, Kanazawa University, Kanazawa, Japan. .; Comprehensive Unit for Health Economic Evidence Review and Decision Support, Ritsumeikan University, Kyoto, Japan. .

Subjects: Cisplatin*/Cisplatin*/Cisplatin*/economics ; Cisplatin*/Cisplatin*/Cisplatin*/therapeutic use ; Cisplatin*/Cisplatin*/Cisplatin*/administration & dosage

  • Source: Journal of gastrointestinal cancer [J Gastrointest Cancer] 2024 Dec; Vol. 55 (4), pp. 1569-1580. Date of Electronic Publication: 2024 Aug 22.Publisher: Springer Country of Publication: United States NLM ID: 101479627 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Cultures derived from pancreatic cancer xenografts with long-term gemcitabine treatment produce chemoresistant secondary xenografts: Establishment of isogenic gemcitabine-sensitive and -resistant models.

Subjects: Deoxycytidine*/Deoxycytidine*/Deoxycytidine*/analogs & derivatives ; Deoxycytidine*/Deoxycytidine*/Deoxycytidine*/pharmacology ; Gemcitabine*

  • Source: Pathology, research and practice [Pathol Res Pract] 2024 Nov; Vol. 263, pp. 155632. Date of Electronic Publication: 2024 Oct 05.Publisher: Gustav Fischer Verlag Country of Publication: Germany NLM ID: 7806109 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Gemcitabine-loaded chitosan nanoparticles enhanced apoptotic and ferroptotic response of gemcitabine treatment alone in the pancreatic cancer cells in vitro.

  • Authors : Aydemir D; School of Medicine, Department of Medical Biochemistry, Koc University, Istanbul, Turkey. .; Koç University Research Center for Translational Medicine (KUTTAM), Istanbul, Turkey. .

Subjects: Chitosan*/Chitosan*/Chitosan*/chemistry ; Gemcitabine* ; Deoxycytidine*/Deoxycytidine*/Deoxycytidine*/analogs & derivatives

  • Source: Naunyn-Schmiedeberg's archives of pharmacology [Naunyn Schmiedebergs Arch Pharmacol] 2024 Nov; Vol. 397 (11), pp. 9051-9066. Date of Electronic Publication: 2024 Jun 17.Publisher: Springer Verlag Country of Publication: Germany NLM ID: 0326264 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
  • 1-10 of  260,386 results for ""Gemcitabine""